Related references
Note: Only part of the references are listed.Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
Rohit Loomba et al.
HEPATOLOGY (2021)
Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
Andryanto Sutanto et al.
NUTRIENTS (2021)
Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study
Aristithes G. Doumouras et al.
CIRCULATION (2021)
Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis
Miller Barreto de Brito e Silva et al.
OBESITY SURGERY (2021)
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
Giuseppe Della Pepa et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies
Julie Steen Pedersen et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Pathology of non-alcoholic fatty liver disease
Ivana Cataldo et al.
PATHOLOGICA (2021)
Does weight loss after laparoscopic sleeve gastrectomy contribute to reduction in blood
Inna Diemieszczyk et al.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2021)
Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis
Evangelos Cholongitas et al.
ANNALS OF GASTROENTEROLOGY (2021)
Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease
Deepa V. Cherla et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2020)
Nonalcoholic Steatohepatitis After Liver Transplantation
Thomas G. Cotter et al.
LIVER TRANSPLANTATION (2020)
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2020)
Bariatric Surgery in Obesity: Effects on Gut Microbiota and Micronutrient Status
Daniela Ciobarca et al.
NUTRIENTS (2020)
Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review
Chelsea S. Pan et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels
Ahmed Abdallah Salman et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
Maurizio Soresi et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
Mengying Yang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron-Wisnewsky et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems
Sophia Marie-Therese Schmitz et al.
BMC GASTROENTEROLOGY (2020)
PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver
Liyun Yuan et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity
Karl Peter Rheinwalt et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Metabolomic Profiles Predict Diabetes Remission after Bariatric Surgery
Jane Ha et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
Anna Jeznach-Steinhagen et al.
MEDICINA-LITHUANIA (2019)
Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
Annette Brandt et al.
SCIENTIFIC REPORTS (2019)
Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria
Dustin Baldwin et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2019)
Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis
Vasiliki Venetsanaki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation
Noemi Cabre et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Yung Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
Ying Luo et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
The effects of bariatric surgery on gut microbiota in patients with obesity: a review of the literature
Izzet Ulker et al.
BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH (2019)
Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
Rosa Divella et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
How bariatric surgery affects liver volume and fat density in NAFLD patients
Ran B. Luo et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2018)
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
Fernando Bril et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
GASTROENTEROLOGY (2018)
Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease-Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production
Valerio Nobili et al.
JOURNAL OF PEDIATRICS (2018)
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
Pegah Golabi et al.
MEDICINE (2018)
2018 Annual Report of the European Liver Transplant Registry (ELTR)-50-year evolution of liver transplantation
Rene Adam et al.
TRANSPLANT INTERNATIONAL (2018)
Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?
Hamza El Hadi et al.
ANTIOXIDANTS (2018)
Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD)
Ma Ai Thanda Han et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease
Paola Dongiovanni et al.
CLINICAL SCIENCE (2017)
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2017)
Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies
Wenjuan Tang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2016)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol
Khalidur Rahman et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The Natural Course of Non-Alcoholic Fatty Liver Disease
Luis Calzadilla Bertot et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Petra Hirsova et al.
JOURNAL OF LIPID RESEARCH (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The role of the gut microbiota in NAFLD
Christopher Leung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
LIRAGLUTIDE IS EFFECTIVE IN THE HISTOLOGICAL CLEARANCE OF NON-ALCOHOLIC STEATOHEPATITIS IN A MULTICENTRE, DOUBLE-BLINDED, RANDOMISED, PLACEBO-CONTROLLED PHASE II TRIAL
M. J. Armstrong et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Effect of Roux-en-y Gastric Bypass on Nonalcoholic Fatty Liver Disease Evaluated Through NAFLD Fibrosis Score: a Prospective Study
Everton Cazzo et al.
OBESITY SURGERY (2015)
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis
Petra Hirsova et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Julia Kozlitina et al.
NATURE GENETICS (2014)
Weight Loss in Nonalcoholic Fatty Liver Disease Patients in an Ambulatory Care Setting Is Largely Unsuccessful but Correlates with Frequency of Clinic Visits
Anwar Dudekula et al.
PLOS ONE (2014)
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease
Nancy Khov et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery
Sten Madsbad et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments
Akira Sasaki et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Characteristics and diagnosis of NAFLD/NASH
Etsuko Hashimoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
The burden of liver disease in Europe: A review of available epidemiological data
Martin Blachier et al.
JOURNAL OF HEPATOLOGY (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Long-Term Effect of Bariatric Surgery on Liver Enzymes in the Swedish Obese Subjects (SOS) Study
Maria Antonella Burza et al.
PLOS ONE (2013)
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD
Z. Permutt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
Hideyuki Hyogo et al.
DIGESTIVE AND LIVER DISEASE (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
Halina Cichoz-Lach et al.
MEDICAL SCIENCE MONITOR (2012)
Lipid Targets During Statin Treatment in Dyslipidemic Patients Affected by Nonalcoholic Fatty Liver Disease
Lorenzo Maroni et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency
Melanie D. Spencer et al.
GASTROENTEROLOGY (2011)
Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy
Scott B. Reeder et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
Histopathology of nonalcoholic fatty liver disease
Elizabeth M. Brunt et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
R. Loomba et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
Philippe Mathurin et al.
GASTROENTEROLOGY (2009)
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
Nicola L. Beer et al.
HUMAN MOLECULAR GENETICS (2009)
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Rajasekhara R. Mummadi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial
Vlad Ratziu et al.
GASTROENTEROLOGY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
Shira Zelber-Sagi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease
S Klein et al.
GASTROENTEROLOGY (2006)
Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease
JM Clark et al.
OBESITY RESEARCH (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
